Search
-
NewFive Galician biotechs attend 'Swiss Biotech Day' with Bioga to explore ways of collaborat...
The conference held in Switzerland is one of Europe's benchmark events in the biotechnology sector, attracting professionals from the global life sciences community.
-
NewBiohope presents its innovative Immunobiogram® for kidney transplantation at the SAN Congr...
Immunobiogram is an in vitro diagnostic device that allows physicians to optimize immunosuppressive therapy on an individualized basis in renal transplant patients.
-
New#AseBioID24 | Keys to the Basque biotech ecosystem that reinforce the potential of AseBio ...
Ane Insausti, Deputy for Economic Promotion and Strategic Projects of the Provincial Council of Gipuzkoa, analyzes the commitment of the Basque Country to innovation and biotechnology.
-
NewNostrum introduces GeoDirDock (GDD), a new model for targeted docking diffusion
The company has also announced that its launch is coming soon.
-
NewThe synergy between biotechnology and immunology catalyzes the development of more effecti...
Biotechnology has achieved significant advances in diagnosis and precision therapies, the production of biotechnological drugs, and the treatment and understanding of infectious, autoimmune, and
-
NewSEBBM organizes the second Severo Ochoa conference
Under the title “Linking the ubiquitin family: physiology, disease and future directions”, SEBBM, together with the Fundación Carmen y Severo Ochoa, is organizing the second Severo Ochoa Conference on
-
NewBioxytol receives green light to start operations in Ávila
The regional government of Castilla y León authorized Bioxytol to develop its projects in Árevalo, Ávila, after evaluating and considering that its development implies a minimum environmental impact.
-
NewBiotechnology and DNA: The duo paving the way for the era of customization in health and a...
Next-generation DNA sequencing has a significant impact on personalized medicine, genomic research, and the identification of genetic diseases.
-
NewMATCH Biosystems, MIKROBIOMIK, and Oniria Therapeutics have been selected for the second e...
The three companies, members of AseBio, work every day to improve treatments and patients' lives through rapid diagnosis of infectious diseases, intestinal microbiota, and precision oncology.
-
NewPhotography of animal experimentation in Spain: the foundation of health advancements unde...
On the occasion of the International Day of the Laboratory Animal, we analyze the legislative and utilization situation of animal experimentation, essential for progress in fields such as oncology
-
NewBiofertilizers and botanical-origin activators are among the biotechnology solutions to ni...
Nitrite water pollution has been a pending issue in Spain for several years. The European Commission already warned about this problem in November 2018, and now, it has been condemned by the European
-
NewQuibim organizes two webinars focused on early detection of prostate cancer and AI
Quibim has held two webinars on the early detection of prostate cancer and the applications of artificial intelligence at clinical levels.
-
NewBCN HEALTH publishes a study evaluating the hospital incidence and medical costs of congen...
BCN HEALTH has published the study ‘Hospital incidence and costs of congenital hydrocephalus in Spain: a multicenter retrospective study’ in the journal ‘Expert Review of Pharmacoeconomics & Outcomes
-
NewVaxdyn and the University of Latvia have obtained funding from the EUROSTARS program to pr...
They receive a grant of half a million euros to prepare the clinical and commercial strategy for vaccination against Klebsiella pneumoniae and Acinetobacter baumannii bacteria.
-
New#AseBioID24 | "These ecosystem events are the best way to develop relationships with inves...
We analyze the challenges and opportunities of the biotechnology sector in areas such as financing and driving its disruptive innovations, led by Antonio López, CEO of SILO, Silver Sponsor of the
-
NewORYZON secures another important patent for its lead CNS asset, vafidemstat
Has received “Intention to Grant” from the European Patent Office.
-
-
NewThe R&D investment of Spanish biotechnology increased by 13% in 2022, surpassing 2.5 billi...
According to the INE, when exclusively analyzing the figures in Companies, R&D investment has increased by 18% compared to 2021: 1.223 billion euros compared to 1.038 billion euros, respectively.
-
New#NewAseBioMember | “AseBio is an important industry association in Spain, representing the...
Meet Owkin, our new member. We talked to its Francisco Miguel Torres, Partnerships Director, Southern Europe.
-
NewThe "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard...
Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally are biotechnological.
-
NewBiotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di...
Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications aimed at alleviating symptoms once the diagnosis has been made.